Psychopharmacology News and Research

RSS

Psychopharmacology is the study of drug-induced changes in mood, sensation, thinking, and behavior.

AKT1 gene moderates mind-altering effects of smoking cannabis in young people

Researchers at the University of Exeter and UCL (University College London) have identified a gene which can be used to predict how susceptible a young person is to the mind-altering effects of smoking cannabis. The finding could help identify otherwise healthy users who are most at risk of developing psychosis.

17 Feb 2016

Study provides new insight into how drug addicts' brains wired differently

A study out today provides new insight into how the brains of drug addicts may be wired differently. The findings, which appear in the journal Psychopharmacology, show that while drug users have very strong motivation to seek out "rewards," they exhibit an impaired ability to adjust their behavior and are less fulfilled once they have achieved what they desire.

11 Feb 2016

New brain imaging technique may help identify children at risk of developing depression

A new brain imaging study from MIT and Harvard Medical School may lead to a screen that could identify children at high risk of developing depression later in life.

22 Jan 2016

Mood disorder experts question effectiveness of metyrapone drug

Pioneering research by mood disorder experts at Newcastle University has questioned the effectiveness of metyrapone, a drug suggested to treat depression.

21 Jan 2016

New study examines link between sexting behavior, relationship satisfaction among married couples

Married couples do report sexting, but it is much less common than in young adult relationships and consists more of intimate talk with their partners than sending nude or nearly nude photos via mobile phones, according to a new study published in Cyberpsychology, Behavior, and Social Networking, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

29 Oct 2015

Nicotine reinforcement demonstrated in study with ‘never-smokers’

In a study with 18 adults who had never smoked, scientists at Johns Hopkins report they have demonstrated one of the earliest steps — nicotine “reinforcement” — in the process of addiction, and shown that some people are far more vulnerable to nicotine addiction than others.

10 Sep 2015

Special issue provides update on mental health diagnosis and treatment of older adults

The aging of the population, shifting diagnostic criteria, and new health care policy initiatives are some of the factors driving changes in mental health treatment for older Americans, according to the September special issue of the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer.

10 Sep 2015

Study points to genetic/metabolic factors that make people vulnerable to nicotine addiction

In a study with 18 adults who had never smoked, scientists at Johns Hopkins report they have demonstrated one of the earliest steps — nicotine "reinforcement" — in the process of addiction, and shown that some people are far more vulnerable to nicotine addiction than others.

10 Sep 2015

Consumption of B-GOS prebiotic has positive effect on gut microbiota, immune systems of elderly people

Clasado Biosciences Limited, the producers and suppliers of the second generation prebiotic Bimuno, a unique trans-galactooligosaccharide, and the Department of Food and Nutritional Sciences, The University of Reading, UK, today announce the results of human research demonstrating the positive effects of an advanced prebiotic on the immune system of the elderly.

29 Jul 2015

Studies using MRI techniques can reveal brain connectivity differences in people with ASD

Studies using magnetic resonance imaging (MRI) techniques are beginning to reveal differences in brain connectivity--the ways that different parts of the brain are connected to each other and work together--in people with autism spectrum disorders (ASD), reports a review in the Harvard Review of Psychiatry.

15 Jul 2015

Amphetamine-based drug Evekeo effective in treating ADHD symptoms in children

The amphetamine-based drug Evekeo, given once or twice daily to children 6-12 years of age, is effective in treating attention-deficit/hyperactivity disorder (ADHD) symptoms and improving performance in a laboratory classroom setting, according to the results of a new study published in the Journal of Child and Adolescent Psychopharmacology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

30 Jun 2015

Cannabis and Cannabinoid Research journal supports President Obama's statement on medical use of marijuana

Mary Ann Liebert, publisher of the newly launched peer-reviewed open access journal Cannabis and Cannabinoid Research, strongly supports President Obama's statement that "...carefully prescribed medical use of marijuana may in fact be appropriate and we should follow the science as opposed to ideology on this issue," when asked about a pending Senate bill seeking to change federal law regarding state-legalized medical marijuana programs.

26 Jun 2015

Study sheds new light on role of patient-doctor relationship in antidepressant drug treatment

A study published in the current issue of Psychotherapy and Psychosomatic sheds new light on the role of patient-doctor relationship in antidepressant drug treatment.

24 Jun 2015

New depression treatment from Magstim to be exhibited at Royal College of Psychiatry International Congress 2015

The Magstim Company Ltd, an innovative and award winning Wales-based medical device manufacturer, will be showing its Magstim Rapid2 Therapy System at the Royal College of Psychiatry International Congress 2015 in Birmingham, UK, 29th June-2nd July.

From Magstim 17 Jun 2015

ADHD drug improves cognitive decline in menopausal women

According to a new study, women experiencing difficulty with time management, attention, organization, memory, and problem solving - often referred to as executive functions - related to menopause may find improvement with a drug already being used to treat attention deficit hyperactivity disorder (ADHD).

12 Jun 2015

New Cannabis and Cannabinoid Research journal to be launched in fall 2015

Cannabis and Cannabinoid Research, a new peer-reviewed, open access journal from Mary Ann Liebert, Inc., publishers, is the only journal dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the biochemical mechanisms of endocannabinoids.

25 Apr 2015

New study explores parent satisfaction with research study on treating severe childhood aggression

A new study of families participating in a clinical trial to treat children with severe physical aggression explored the factors affecting parent satisfaction with the research study.

21 Apr 2015

Study suggests possible role for caffeine in AD treatment

The proposed link between caffeine and reductions in the beta amyloid plaque accumulation characteristic of Alzheimer's disease (AD) suggest a possible role for caffeine in AD treatment. The latest evidence linking beta amyloid protein to Alzheimer's disease and exploring the relationship between caffeine and beta amyloid are featured in a review article in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

31 Mar 2015

AJN honors six of Elsevier's nursing book titles with Book of the Year awards

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today that six of its nursing book titles are recipients of the American Journal of Nursing (AJN) Book of the Year awards.

30 Mar 2015

Use of psychedelic drugs linked to less psychological distress, fewer suicidal thoughts

A history of psychedelic drug use is associated with less psychological distress and fewer suicidal thoughts, planning and attempts, according to new research from Johns Hopkins and the University of Alabama at Birmingham.

10 Mar 2015

Psychopharmacology News and Research

Further Reading

AKT1 gene moderates mind-altering effects of smoking cannabis in young people

Study provides new insight into how drug addicts' brains wired differently

New brain imaging technique may help identify children at risk of developing depression

Mood disorder experts question effectiveness of metyrapone drug

New study examines link between sexting behavior, relationship satisfaction among married couples

Nicotine reinforcement demonstrated in study with ‘never-smokers’

Special issue provides update on mental health diagnosis and treatment of older adults

Study points to genetic/metabolic factors that make people vulnerable to nicotine addiction

Consumption of B-GOS prebiotic has positive effect on gut microbiota, immune systems of elderly people

Studies using MRI techniques can reveal brain connectivity differences in people with ASD

Amphetamine-based drug Evekeo effective in treating ADHD symptoms in children

Cannabis and Cannabinoid Research journal supports President Obama's statement on medical use of marijuana

Study sheds new light on role of patient-doctor relationship in antidepressant drug treatment

New depression treatment from Magstim to be exhibited at Royal College of Psychiatry International Congress 2015

ADHD drug improves cognitive decline in menopausal women

New Cannabis and Cannabinoid Research journal to be launched in fall 2015

New study explores parent satisfaction with research study on treating severe childhood aggression

Study suggests possible role for caffeine in AD treatment

AJN honors six of Elsevier's nursing book titles with Book of the Year awards

Use of psychedelic drugs linked to less psychological distress, fewer suicidal thoughts

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News